TCR1188-ABC Cells in KRAS-mutated Cancers
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Pancreatic Adenocarcinoma
Related studies linked through entity extraction aliases.
A Phase Ⅰ Study of CS08399 in Participants With MTAP-deleted Solid Tumors and Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic Adenocarcinoma
- Status
- AVAILABLE
- Phase
- N/A
A Phase I Study to Evaluate the Safety and Efficacy of L19IL2 in Combination With Ruxolitinib in Patients With Advanced Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Lorigerlimab (MGD019) in Patients With Pancreatic Adenocarcinoma and Homologous Recombination Deficiency
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE3
Superior Mesenteric Artery First Versus Standard Approach in Pancreaticoduodenectomy
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE3
FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers
- Status
- RECRUITING
- Phase
- PHASE2
Sotorasib Combined With First-line Chemotherapy for Advanced Pancreatic Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE1
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Alpha Radiation Emitters Device (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
- Status
- RECRUITING
- Phase
- NA
Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Multicenter Trial of ESK981 in Patients With Select Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Prospective Validation of an EHR-based Pancreatic Cancer Risk Model
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Study of LP-184 in Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Status
- RECRUITING
- Phase
- PHASE1
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Personalized Vaccine With SOC Chemo Followed by Nivo in Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1